[go: up one dir, main page]

AU2179088A - Pyridylethanolamines - Google Patents

Pyridylethanolamines

Info

Publication number
AU2179088A
AU2179088A AU21790/88A AU2179088A AU2179088A AU 2179088 A AU2179088 A AU 2179088A AU 21790/88 A AU21790/88 A AU 21790/88A AU 2179088 A AU2179088 A AU 2179088A AU 2179088 A AU2179088 A AU 2179088A
Authority
AU
Australia
Prior art keywords
acid addition
addition salts
diastereomers
effect
novel compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU21790/88A
Other versions
AU617353B2 (en
Inventor
Wolfgang Grell
Rudolf Hurnaus
Michael Mark
Manfred Reiffen
Eckhard Rupprecht
Robert Sauter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of AU2179088A publication Critical patent/AU2179088A/en
Application granted granted Critical
Publication of AU617353B2 publication Critical patent/AU617353B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Pyridylethanolamines of the formula <IMAGE> in which R denotes a carboxymethoxy, carbomethoxymethoxy, ethoxycarbonylmethoxy or 2-hydroxyethoxy group, their optical isomers, their diastereomers and their acid addition salts. The novel compounds of the above formula I, their optical isomers and their diastereomers and also their acid addition salts, in particular their physiologically tolerable acid addition salts with inorganic or organic acids, have useful pharmacological properties, namely an effect on the metabolism, preferably a hypoglycaemic and body fat-reducing effect, and also a lowering effect on the atherogenic beta -lipoproteins VLDL and LDL. The novel compounds of the above formula I can be prepared by processes which are known per se.
AU21790/88A 1987-09-02 1988-09-01 Pyridylethanolamines Ceased AU617353B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3729284 1987-09-02
DE19873729284 DE3729284A1 (en) 1987-09-02 1987-09-02 NEW HETEROARYLETHANOLAMINES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Publications (2)

Publication Number Publication Date
AU2179088A true AU2179088A (en) 1989-03-02
AU617353B2 AU617353B2 (en) 1991-11-28

Family

ID=6335037

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21790/88A Ceased AU617353B2 (en) 1987-09-02 1988-09-01 Pyridylethanolamines

Country Status (13)

Country Link
EP (1) EP0305845B1 (en)
JP (1) JPH0196172A (en)
KR (1) KR890005056A (en)
AT (1) ATE81851T1 (en)
AU (1) AU617353B2 (en)
CA (1) CA1331005C (en)
DE (2) DE3729284A1 (en)
DK (1) DK486988A (en)
FI (1) FI884003L (en)
IL (1) IL87620A0 (en)
NZ (1) NZ226006A (en)
PT (1) PT88392B (en)
ZA (1) ZA886501B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617341B2 (en) * 1987-08-07 1991-11-28 Syngenta Participations Ag 1-nitro-2,2-diaminoethylene derivatives

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4006794A1 (en) * 1990-03-03 1991-09-05 Bayer Ag METHOD FOR PRODUCING AMINOETHANOL DERIVATIVES
NZ537635A (en) * 2002-07-17 2006-11-30 Lek Pharmaceuticals D Novel derivatives of pyridylethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, processes for their preparation, and pharmaceutical compositions containing them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615293A1 (en) * 1986-05-06 1987-11-12 Bayer Ag USE OF HETEROARYLETHYLAMINE FOR PERFORMANCE IN ANIMALS, HETEROARYLETHYLAMINE AND METHOD FOR THE PRODUCTION THEREOF
CA1287061C (en) * 1986-06-27 1991-07-30 Roche Holding Ltd. Pyridine ethanolamine derivatives
DE3627663A1 (en) * 1986-08-14 1988-03-03 Bayer Ag HETEROARYLETHYLAMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A PERFORMANCE IN ANIMALS
ES2021105B3 (en) * 1987-03-07 1991-10-16 Bayer Ag PROCEDURE FOR OBTAINING 5-AMINO-4,6-DIHALOGEN PIRIDINES.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617341B2 (en) * 1987-08-07 1991-11-28 Syngenta Participations Ag 1-nitro-2,2-diaminoethylene derivatives

Also Published As

Publication number Publication date
DK486988A (en) 1989-03-03
PT88392B (en) 1992-10-30
ATE81851T1 (en) 1992-11-15
NZ226006A (en) 1991-05-28
DE3729284A1 (en) 1989-03-23
IL87620A0 (en) 1989-01-31
FI884003A7 (en) 1989-03-03
ZA886501B (en) 2008-05-30
PT88392A (en) 1989-07-31
DE3875563D1 (en) 1992-12-03
AU617353B2 (en) 1991-11-28
EP0305845B1 (en) 1992-10-28
EP0305845A1 (en) 1989-03-08
FI884003L (en) 1989-03-03
FI884003A0 (en) 1988-08-31
CA1331005C (en) 1994-07-26
DK486988D0 (en) 1988-09-01
JPH0196172A (en) 1989-04-14
KR890005056A (en) 1989-05-11

Similar Documents

Publication Publication Date Title
SE9600797L (en) New salts
AU681198B2 (en) Preparation of 3,4,4-trisubstituted-piperidinyl-N- alkylcarboxylates and intermediates
FR2564859B1 (en) PROCESS FOR THE PREPARATION OF HYALURONIC ACID BY FERMENTATION.
AU1331588A (en) Method for treatment of alcohol abuse
KR100189590B1 (en) Method for inhibiting gastric acid secretion with 8-substituted-2-amino-1,2,3,4-tetrahydronapthalene
AU581442B2 (en) 2-substituted-1, 3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
AU570761B2 (en) Substituted 5,11-dihydro-6h-dibenz (b,e) azepm-6-ones
EP0393424A3 (en) Process for the preparation of 2,7-Diazabicyclo(3.3.O)octanes
PL300747A1 (en) Method of obtaining substantially pure clavulanic acid
AU2179088A (en) Pyridylethanolamines
IE882255L (en) Preparation of quinolonecarboxylic acids
EG19007A (en) Process for preparing of enantiomeric glutaramide diuretic agents
CA2130618A1 (en) Stereoselective process for preparing .beta.-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonate intermediates
IL99263A0 (en) Process for the preparation of crystalline taca
AU1745288A (en) Process for the preparation of 4,4&#39;-dinitrostilbene-2,2&#39;-disulfonic acid
GB8606204D0 (en) Biosynthetic anthracyclines
AU1099888A (en) Novel imidazo- and triazolothiadiazines, a process for the preparation thereof, medicaments containing same, and the use thereof, and some intermediates formed in the preparation of the compounds mentioned
IE890232L (en) Condensed diazepinones
CA2126090A1 (en) Process for preparing neuraminidase
ATA214393A (en) PROCESS FOR THE PREPARATION OF 7-AMINO-3-CEPHEM-4-CARBONIC ACID DERIVATIVES
HU9302786D0 (en) New thiophene-2-carboxylic acid derivatives and process for preparing them
EP0429751A3 (en) Substituted 3-amino-sydnonimines, process for their preparation and their use
GR3004354T3 (en)
AU1259488A (en) Process for the preparation of 5-hydroxydiprafenone and its acid addition salts
CS934687A1 (en) Method of cis-2,2-dimethyl-3-(2,2-dihalovinyl) cyclopropancarboxylic acid&#39;s optical isomers preparation